Form 8-K - Current report:
SEC Accession No. 0001558370-24-014663
Filing Date
2024-11-06
Accepted
2024-11-06 16:56:49
Documents
15
Period of Report
2024-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pahc-20241105x8k.htm   iXBRL 8-K 46118
2 EX-99.1 pahc-20241105xex99d1.htm EX-99.1 393865
3 GRAPHIC pahc-20241105xex99d1001.jpg GRAPHIC 9566
  Complete submission text file 0001558370-24-014663.txt   599695

Data Files

Seq Description Document Type Size
4 EX-101.SCH pahc-20241105.xsd EX-101.SCH 3256
5 EX-101.LAB pahc-20241105_lab.xml EX-101.LAB 15901
6 EX-101.PRE pahc-20241105_pre.xml EX-101.PRE 10317
17 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20241105x8k_htm.xml XML 4929
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 241431929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)